At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference.
 

Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact.
 

We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together.

Job Description
 

Gilead is looking for an Executive Director - Gilead Asset Team Leader (GATL) – Inflammation Partnership —a role where your work can help advance life‑changing scientific innovation and meaningful patient impact.

Jointly reporting to the Commercial and Development Therapeutic Area Heads, the Gilead Asset Team Leader (GATL) is an enterprise leader responsible for leading the cross-functional asset team and shaping the asset vision, strategic direction, and lifecycle plan (LCP) including across multiple indications and drug combinations.

Serving as the primary liaison for senior leadership within the governance model, the GATL drives collaboration across Gilead, engaging diverse stakeholders involved in the development, manufacturing, and commercialization of an asset, to ensure optimal program execution in alignment with the asset strategy and the LCP. 

This senior role requires a diverse set of experiences across Development and Commercialization functions and relies on a record of achievement for optimizing asset outcomes. This role demands adept navigation of complex programmatic challenges and excellent enterprise-level leadership.

Specific Responsibilities:

This Initially, this GATL will lead a team's covering a novel asset that is expected to initiate Phase 3s for multiple diverse indications starting next year, along with several Phase 1/2s. This particular asset is co-developed with a partner, involving strong collaboration for a cohesive end to end strategy.  As the Inflammation and Immunology pipeline continues to evolve, specific assets may change over time. multiple assets, from early- to late-phase across immunology. 

• Strategic Asset Leadership: Lead Gilead asset teams in developing and executing cohesive asset and program strategies, ensuring alignment with Gilead’s broader organizational goals through effective resource assessment, timeline management, and risk mitigation.  

• Cross-functional Collaboration: With a clear understanding of each function’s role and value, enable strong collaboration around a shared asset vision, ensuring transparent and effective flow of asset‑related information and decisions across teams and partners.

• Accountability for Delivery: Assume responsibility for the timely achievement of key asset-related milestones. In conjunction with the Project Manager, monitoring progress against the Target Product Profile (TPP), Asset Plan, and Lifecycle Plan (LCP), and ensuring adherence to timelines and budgets.

• Integrated Strategy Development: Develop and present comprehensive global asset strategies encompassing product development, manufacturing, commercialization and lifecycle management, adapting plans as clinical, regulatory, or commercial landscapes evolve.  Collaborate with an external partner for cohesive end to end strategy.

• Governance and Decision Facilitation: Act as decision facilitator, incorporating cross-functional insights to resolve high-impact issues, drive scenario planning and risk analysis, and communicate transparently with senior leadership and governance bodies. Ensures ongoing scientific and commercial viability of the program. Sets clear Go/No Go decision points and objectively presents data to Portfolio Committee.

• Team Leadership: With an enterprise mindset, align cross‑functional teams around a unified asset vision, fostering clarity of roles and accountability, and cultivating a high‑performing, inclusive and collaborative team environment that drives productive debate, cohesive strategy execution and decision‑making.

• Stakeholder Engagement: Build and maintain strong relationships with internal and external partners to support program success and innovation.

• Operational Excellence: Ensure excellence in operationalization of integrated asset strategy and stakeholder activities according to strategic directives to deliver on program milestones.

• Scientific and Medical Advocacy: Effectively articulate and champion asset strategies, scientific rationale, and clinical objectives to diverse audiences, supporting Gilead’s reputation and mission.

• Portfolio and Therapeutic Area Strategy: Collaborate with Therapeutic Area Leaders and Business Development to advise on disease area strategies for discovery, innovation, development, and lifecycle planning.

Capabilities and Requirements:

• Advanced scientific, medical, or commercial background with expertise in drug development and relevant therapeutic areas, and proven ability to make complex decisions with an enterprise perspective.

• Demonstrated cross-functional leadership across global initiatives, effectively managing projects, and executing strategic plans.

• Proven ability to lead multidisciplinary teams and integrate discovery, development, regulatory, and commercial considerations across all asset lifecycle phases.

• Able to lead, influence, and deliver significant impact even in the absence of direct authority.

• Exceptional communication, organizational, and decision-making skills, able to resolve complex issues and influence senior leaders and external partners.

• Track record of high-level performance and strategic value delivery within global pharmaceutical or biotech organizations.

• Comprehensive understanding of the drug development process, including full asset lifecycle management and end-to-end brand exposure.

Basic Qualifications:

Bachelor's Degree and Fourteen Years’ Experience

OR

Masters' Degree and Twelve Years’ Experience

OR

PhD and Twelve Years’ Experience

Preferred Qualifications:

• Bachelor’s degree in a scientific or business discipline required; advanced degrees such as PhD, MD, or MBA highly preferred. For some GATL roles, an MD or PhD may be prioritized.

• 12+ years’ biopharmaceutical industry experience preferred, with at least 8 years in relevant roles within biotech/pharmaceutical organizations.

• Comprehensive knowledge of the overall drug development process, with experience in commercial launches and program/asset strategy teams strongly desired.

People Leader Accountabilities

•Create Inclusion - knowing the business value of diverse teams, modeling inclusion, and embedding the value of diversity in the way they manage their teams.

•Develop Talent - understand the skills, experience, aspirations, and potential of their employees and coach them on current performance and future potential. They ensure employees are receiving the feedback and insight needed to grow, develop, and realize their purpose.

•Empower Teams - connect the team to the organization by aligning goals, purpose, and organizational objectives and holding them to account. They provide the support needed to remove barriers and connect their team to the broader ecosystem.

 

The salary range for this position is: $302,005.00 - $390,830.00. Gilead considers a variety of factors when determining base compensation, including experience, qualifications, and geographic location. These considerations mean actual compensation will vary. This position may also be eligible for a discretionary annual bonus, discretionary stock-based long-term incentives (eligibility may vary based on role), paid time off, and a benefits package. Benefits include company-sponsored medical, dental, vision, and life insurance plans*.

For additional benefits information, visit:

https://www.gilead.com/careers/compensation-benefits-and-wellbeing

* Eligible employees may participate in benefit plans, subject to the terms and conditions of the applicable plans.

For jobs in the United States:

Gilead Sciences Inc. is committed to providing equal employment opportunities to all employees and applicants for employment, and is dedicated to fostering an inclusive work environment comprised of diverse perspectives, backgrounds, and experiences. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, sex, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression, veteran status, or other non-job related characteristics or other prohibited grounds specified in applicable federal, state and local laws. In order to ensure reasonable accommodation for individuals protected by Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veterans' Readjustment Act of 1974, and Title I of the Americans with Disabilities Act of 1990, applicants who require accommodation in the job application process may contact ApplicantAccommodations@gilead.com for assistance.

For more information about equal employment opportunity protections, please view the 'Know Your Rights' poster.

NOTICE: EMPLOYEE POLYGRAPH PROTECTION ACT
YOUR RIGHTS UNDER THE FAMILY AND MEDICAL LEAVE ACT

Gilead Sciences will not discharge or in any other manner discriminate against employees or applicants because they have inquired about, discussed, or disclosed their own pay or the pay of another employee or applicant. However, employees who have access to the compensation information of other employees or applicants as a part of their essential job functions cannot disclose the pay of other employees or applicants to individuals who do not otherwise have access to compensation information, unless the disclosure is (a) in response to a formal complaint or charge, (b) in furtherance of an investigation, proceeding, hearing, or action, including an investigation conducted by the employer, (c) consistent with the  legal duty to furnish information; or (d) otherwise protected by law.
 

Our environment respects individual differences and recognizes each employee as an integral member of our company. Our workforce reflects these values and celebrates the individuals who make up our growing team.

Gilead provides a work environment free of harassment and prohibited conduct. We promote and support individual differences and diversity of thoughts and opinion.

For Current Gilead Employees and Contractors:

Please apply via the Internal Career Opportunities portal in Workday.